Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroblastoma × Sorafenib × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 62 Carcinoma, Renal Cell 35 Liver Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Breast Neoplasms 14 Neoplasms 13 Neoplasm Metastasis 13 Melanoma 12 Leukemia, Myeloid, Acute 10 Sarcoma 9 Thyroid Neoplasms 8 Lung Neoplasms 8 Kidney Neoplasms 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 6 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Glioblastoma 4 Carcinoma, Medullary 4 Breast Neoplasms, Male 4 Brain Neoplasms 4 Thyroid Diseases 3 Thyroid Carcinoma, Anaplastic 3 Stomach Neoplasms 3 Recurrence 3 Osteosarcoma 3 Myelodysplastic Syndromes 3 Leiomyosarcoma 3 Hemangiosarcoma 3

Interventions

Cyclophosphamide 29 Etoposide 21 Isotretinoin 18 Topotecan 16 Temozolomide 16 Doxorubicin 16 Irinotecan 15 Carboplatin 15 Vincristine 14 sargramostim 13 Melphalan 12 Granulocyte-Macrophage Colony-Stimulating Factor 12 3-Iodobenzylguanidine 12 Radiotherapy 11 Cisplatin 11 dinutuximab 10 Magnetic Resonance Spectroscopy 9 Filgrastim 9 naxitamab 8 Peripheral Blood Stem Cell Transplantation 8 Thiotepa 7 humanized 3F8 anti-GD2 monoclonal antibody 6 X-Rays 6 Specimen Handling 6 Phantoms, Imaging 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Antilymphocyte Serum 6 fludarabine phosphate 5 aldesleukin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02559778 2026-02-20

PEDS-PLAN

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡